T1	PROC 1 11	Evaluación
#1	AnnotatorNotes T1	C1261322; Evaluation procedure; Health Care Activity
T2	CHEM 18 30	nitazoxanida
#2	AnnotatorNotes T2	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T3	DISO 65 87	parasitosis intestinal
#3	AnnotatorNotes T3	C0021832; Intestinal Diseases, Parasitic; Disease or Syndrome
T4	PROC 99 118	Evaluar la utilidad
T5	CHEM 122 134	nitazoxanida
#4	AnnotatorNotes T5	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T6	PROC 204 249	erradicación masiva de parásitos intestinales
T7	ANAT 237 249	intestinales
#5	AnnotatorNotes T7	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T8	CHEM 310 320	albendazol
#6	AnnotatorNotes T8	C0001911; albendazole; Organic Chemical · Pharmacologic Substance
T9	CHEM 1607 1623	quimiopreventivo
#7	AnnotatorNotes T9	C1516463; Chemopreventive Agent; Pharmacologic Substance
T10	PROC 534 545	tratamiento
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	CHEM 717 727	albendazol
#9	AnnotatorNotes T11	C0001911; albendazole; Organic Chemical · Pharmacologic Substance
T12	CHEM 800 812	nitazoxanida
#10	AnnotatorNotes T12	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T13	CHEM 928 940	nitazoxanida
#11	AnnotatorNotes T13	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T14	PROC 1141 1152	tratamiento
#12	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	CHEM 1166 1176	albendazol
#13	AnnotatorNotes T15	C0001911; albendazole; Organic Chemical · Pharmacologic Substance
T16	CHEM 1228 1240	nitazoxanida
#14	AnnotatorNotes T16	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T17	DISO 1309 1328	efectos secundarios
#15	AnnotatorNotes T17	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T18	CHEM 1333 1345	nitazoxanida
#16	AnnotatorNotes T18	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T19	CHEM 1429 1439	albendazol
#17	AnnotatorNotes T19	C0001911; albendazole; Organic Chemical · Pharmacologic Substance
T20	DISO 1530 1549	efectos secundarios
#18	AnnotatorNotes T20	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T21	CHEM 1556 1568	nitazoxanida
#19	AnnotatorNotes T21	C0068788; nitazoxanide; Organic Chemical · Pharmacologic Substance
T22	DISO 1730 1752	parasitosis intestinal
#20	AnnotatorNotes T22	C0021832; Intestinal Diseases, Parasitic; Disease or Syndrome
T23	PROC 1768 1787	prevención primaria
#21	AnnotatorNotes T23	C0033144; Primary Prevention; Therapeutic or Preventive Procedure
T24	CHEM 1930 1934	agua
#22	AnnotatorNotes T24	C0043047; water; Pharmacologic Substance · Inorganic Chemical
T25	ANAT 1956 1964	excretas
#23	AnnotatorNotes T25	C0015733; Feces; Body Substance
T26	PROC 1998 2021	educación para la salud
#24	AnnotatorNotes T26	C0018701; Health education; Educational Activity
T27	ANAT 77 87	intestinal
#25	AnnotatorNotes T27	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T28	PROC 372 399	ensayo clínico aleatorizado
#26	AnnotatorNotes T28	C0206034; Clinical Trials, Randomized; Research Activity
T29	PROC 620 641	examen parasitológico
T30	DISO 1650 1672	parasitosis intestinal
#27	AnnotatorNotes T30	C0021832; Intestinal Diseases, Parasitic; Disease or Syndrome
T31	ANAT 1662 1672	intestinal
#28	AnnotatorNotes T31	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T32	ANAT 1742 1752	intestinal
#29	AnnotatorNotes T32	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T33	CHEM 1893 1897	agua
#30	AnnotatorNotes T33	C0043047; water; Pharmacologic Substance · Inorganic Chemical
T34	Dose 34 45	dosis única
T35	Duration 52 61	tres días
T36	Duration 168 177	tres días
T37	Dose 183 194	dosis única
T38	LIVB 227 236	parásitos
#31	AnnotatorNotes T38	C0030498; Parasites; Eukaryote
T39	Dose 324 335	dosis única
T40	LIVB 409 428	comunidades rurales
#32	AnnotatorNotes T40	C0086944; Rural Communities; Population Group
T41	Date 480 484	2001
T42	Date 485 489	2003
T44	LIVB 553 560	sujetos
#33	AnnotatorNotes T44	C0681850; Study Subject; Group
T45	Age 564 581	entre 5 y 11 años
T46	LIVB 682 691	pacientes
#34	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Dose 707 713	400 mg
T48	Dose 731 742	dosis única
T49	LIVB 766 775	pacientes
#35	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Dose 825 833	15 mg/kg
T51	Frequency 833 837	/día
T52	Duration 846 868	tres días consecutivos
T53	LIVB 894 903	pacientes
#36	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Dose 919 924	1.2 g
T55	Dose 944 955	dosis única
T57	Frequency 1353 1357	/día
T58	Dose 1371 1382	dosis única
T59	Dose 1414 1425	dosis única
T60	Neg_cue 1569 1571	no
T61	LIVB 1968 1987	animales domésticos
#37	AnnotatorNotes T61	C0003063; Animals, Domestic; Animal
T62	LIVB 256 276	población pediátrica
#38	AnnotatorNotes T62	C1257890; Population; Population Group + C0008059; Child; Age Group
A1	Population_data T62 Age
A2	Assertion T9 Negated
R1	Negation Arg1:T60 Arg2:T9	
T43	Neg_cue 1041 1043	No
T56	CONC 1055 1066	diferencias
A3	Assertion T56 Negated
#39	AnnotatorNotes T56	C1705241; Delta (difference); Quantitative Concept
R2	Negation Arg1:T43 Arg2:T56	
T63	Spec_cue 509 517	posibles
T64	CONC 518 530	alternativas
A4	Assertion T64 Speculated
#40	AnnotatorNotes T64	C1523987; Alternative; Qualitative Concept
R3	Speculation Arg1:T63 Arg2:T64	
R4	Has_Dose_or_Strength Arg1:T2 Arg2:T34	
R5	Has_Duration_or_Interval Arg1:T2 Arg2:T35	
R6	Location_of Arg1:T27 Arg2:T3	
R7	Has_Duration_or_Interval Arg1:T5 Arg2:T36	
R8	Has_Dose_or_Strength Arg1:T5 Arg2:T37	
R9	Used_for Arg1:T5 Arg2:T6	
R10	Location_of Arg1:T7 Arg2:T38	
R11	Experiences Arg1:T62 Arg2:T5	
R12	Experiences Arg1:T62 Arg2:T6	
R13	Experiences Arg1:T62 Arg2:T8	
R14	Has_Dose_or_Strength Arg1:T8 Arg2:T39	
R15	After Arg1:T28 Arg2:T41	
R16	Before Arg1:T28 Arg2:T42	
R17	Experiences Arg1:T40 Arg2:T10	
R18	Experiences Arg1:T44 Arg2:T10	
R19	Has_Age Arg1:T44 Arg2:T45	
R20	Experiences Arg1:T44 Arg2:T29	
R21	Before Arg1:T29 Arg2:T10	
R22	Experiences Arg1:T40 Arg2:T29	
T65	Result_or_Value 642 650	positivo
#41	AnnotatorNotes T65	C1446409; Positive; Finding
R23	Has_Result_or_Value Arg1:T29 Arg2:T65	
R24	Experiences Arg1:T46 Arg2:T11	
R25	Has_Dose_or_Strength Arg1:T11 Arg2:T47	
R26	Has_Dose_or_Strength Arg1:T11 Arg2:T48	
R27	Experiences Arg1:T49 Arg2:T12	
R28	Has_Dose_or_Strength Arg1:T12 Arg2:T50	
R29	Has_Frequency Arg1:T12 Arg2:T51	
R30	Has_Duration_or_Interval Arg1:T12 Arg2:T52	
R31	Experiences Arg1:T53 Arg2:T13	
R32	Has_Dose_or_Strength Arg1:T13 Arg2:T54	
R33	Has_Dose_or_Strength Arg1:T13 Arg2:T55	
T66	CONC 1003 1026	prueba exacta de Fisher
#42	AnnotatorNotes T66	C1708064; Fisher's Exact Test; Intellectual Product
T67	Quantifier_or_Qualifier 1067 1098	estadísticamente significativas
A5	Assertion T67 Negated
#43	AnnotatorNotes T67	C0237881; Statistical Significance; Quantitative Concept
R34	Has_Quantifier_or_Qualifier Arg1:T56 Arg2:T67	
R35	Negation Arg1:T43 Arg2:T67	
R36	Used_for Arg1:T15 Arg2:T14	
R37	Used_for Arg1:T16 Arg2:T14	
R38	Causes Arg1:T18 Arg2:T17	
R39	Has_Frequency Arg1:T18 Arg2:T57	
R40	Has_Dose_or_Strength Arg1:T18 Arg2:T58	
R41	Has_Dose_or_Strength Arg1:T19 Arg2:T59	
R42	Causes Arg1:T19 Arg2:T17	
R43	Causes Arg1:T21 Arg2:T20	
R44	Location_of Arg1:T31 Arg2:T30	
R45	Location_of Arg1:T32 Arg2:T22	
R46	Before Arg1:T23 Arg2:T22	
T68	Quantifier_or_Qualifier 1898 1905	potable
R47	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T68	
T69	PROC 1639 1672	control de parasitosis intestinal
R48	Used_for Arg1:T21 Arg2:T69	
R49	Used_for Arg1:T9 Arg2:T69	
T70	Observation 292 298	efecto
#44	AnnotatorNotes T70	C1518681; Outcome of Therapy; Finding (?)
R50	Causes Arg1:T8 Arg2:T70	
R51	Causes Arg1:T5 Arg2:T70	
#45	AnnotatorNotes T29	C1294355; Detection of parasite; Laboratory Procedure
A6	Experiencer T62 Patient
A7	Experiencer T40 Patient
A8	Experiencer T44 Patient
A9	Experiencer T46 Patient
A10	Experiencer T49 Patient
A11	Experiencer T53 Patient
